Patents by Inventor Xiao Min Schebye

Xiao Min Schebye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-GITR antibodies
    Patent number: 9701751
    Abstract: Antibodies to human GITR are provided, as well as uses thereof, e.g., in treatment of proliferative and immune disorders.
    Type: Grant
    Filed: April 24, 2014
    Date of Patent: July 11, 2017
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Xiao Min Schebye, Grigori P. Ermakov, Douglas J. Hodges, Leonard G. Presta
  • ANTI-GITR ANTIBODIES
    Publication number: 20140348841
    Abstract: Antibodies to human GITR are provided, as well as uses thereof, e.g., in treatment of proliferative and immune disorders.
    Type: Application
    Filed: April 24, 2014
    Publication date: November 27, 2014
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Xiao Min Schebye, Grigori P. Ermakov, Douglas J. Hodges, Leonard G. Presta
  • Anti-GITR antibodies
    Patent number: 8709424
    Abstract: Antibodies to human GITR are provided, as well as uses thereof, e.g., in treatment of proliferative and immune disorders.
    Type: Grant
    Filed: August 31, 2010
    Date of Patent: April 29, 2014
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Xiao Min Schebye, Grigori P. Ermakov, Douglas J. Hodges, Leonard G. Presta
  • ANTI-GITR ANTIBODIES
    Publication number: 20120189639
    Abstract: Antibodies to human GITR are provided, as well as uses thereof, e.g., in treatment of proliferative and immune disorders.
    Type: Application
    Filed: August 31, 2010
    Publication date: July 26, 2012
    Applicant: Schering Corporation
    Inventors: Xiao Min Schebye, Grigory P. Ermakov, Douglas J. Hodges, Leonard G. Presta
  • cDNAs expressed in adipocyte differentiation
    Publication number: 20030113720
    Abstract: The present invention relates to a composition comprising a plurality of cDNAs which are expressed during adipocyte differentiation, particularly in disorders associated with obesity and type II diabetes, and which may be used, in their entirety or in part, to diagnose, to stage, to treat, or to monitor the progression or treatment of such disorders.
    Type: Application
    Filed: July 30, 2001
    Publication date: June 19, 2003
    Inventors: Xiao Min Schebye, Thierry Sornasse
  • Genes regulated by peroxisome proliferator-activated receptor gamma agonist
    Publication number: 20030096272
    Abstract: The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed in response to peroxisome proliferator-activated receptor gamma (PPAR&ggr;) agonist and which may be used entirely or in part to diagnose, to stage, to treat, or to monitor the progression or treatment of disorders such as diabetes mellitus, obesity, hypertension, atherosclerosis, polycystic ovarian syndrome, and cancers of the breast, prostate, or colon.
    Type: Application
    Filed: July 29, 2002
    Publication date: May 22, 2003
    Applicant: Incyte Genomics, Inc.
    Inventor: Xiao Min Schebye